Dr. Waltzman’s panel, titled “Ensuring Effective and Efficient Trials Through Clinical Operations” will be Monday, April 7 th from 4:05PM – 4:35PM ET.

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration ...

pancreatic and non-Hodgkin’s lymphomas in standard pre-clinical models, including syngeneic mouse tumors and human tumor xenografts. In pre-clinical studies tumor eradication was observed with Decoy ...

Centre for 3D models of Health and Disease, Division of Surgery and Interventional Science, University College London, London W1W 7TY, U.K. Centre for 3D models of Health and Disease, Division of ...

The model could help test the ability of different drugs in treating pancreatic cancer. Image credit: Shutterstock / Lightspring. A team of German scientists and biotech company Dynamic42 have jointly ...

AI models are being cranked out at a dizzying pace, by everyone from Big Tech companies like Google to startups like OpenAI and Anthropic. Keeping track of the latest ones can be overwhelming.

Silexion Therapeutics Corp. announced promising results from preclinical studies of its RNA interference therapy, SIL204, for KRAS-driven pancreatic cancer. The research, conducted in orthotopic ...

Grand Cayman, Cayman Islands, March 05, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA ...

(MENAFN- GlobeNewsWire - Nasdaq) Silexion Therapeutics' Latest Data Demonstrates that Subcutaneously Administered SIL204 Reduces Both Primary Tumors and Metastases in Clinically Relevant ...

The team is also exploring a strategy to direct similar nanoparticles to the spleen—a key immune organ that assists immune defense at the original pancreatic cancer site.

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...